Clinical and Experimental Nephrology

, Volume 22, Issue 5, pp 1157–1162 | Cite as

Hypertension and its severity in children with steroid sensitive nephrotic syndrome during remission

  • Swasti Keshri
  • Shobha SharmaEmail author
  • Neha Agrawal
  • Sandeep Bansal
  • B. P. Guilliani
  • Kailash Chandra Aggrawal
Original article


Background and objective

Hypertension is not a typical feature of steroid sensitive nephrotic syndrome (SSNS) and the presence of persistent hypertension is suggestive of significant renal lesion. There is paucity of data regarding occurrence and severity of hypertension in SSNS in pediatric population during remission and was the main objective of this study. In addition, correlation with factors like family history, BMI, and lipid profile was studied.


Cross-sectional study conducted at tertiary care center in India including 81 children of infrequent relapsing SSNS between 1 and 10 years in remission and was off steroids. Grading and severity of hypertension were assessed. Statistical analysis was done using SPSS version 21.0.


Median age of presentation was 5 years, with male:female ratio of 1.3:1. Out of 81 infrequent relapsing SSNS children, 23.45% (19) had hypertension. Among those children with hypertension (n = 19), 73.68% (14) had positive family history compared to 32.25% (20) in those without hypertension. Positive correlation was found between BP and serum cholesterol and LDL. Of the hypertensive patients, 1 (5.26%) had fundus changes, 2 (10.52%) had features of left ventricular hypertrophy, and 13 (68.42%) had non-nephrotic range proteinuria.


There is high incidence of hypertension in NS children during remission. Though significant positive correlation was found with positive family history of hypertension and deranged lipid profile highlighting possibility of essential hypertension in them, there is need for close active monitoring and management of hypertension in them as untreated cases may have significant target organ damage.


Hypertension Nephrotic syndrome Children 


Compliance with ethical standards

Conflict of interest

Authors have declared that no conflict of interest exists.

Ethical approval

IRB committee approval has been obtained.

Informed consent

Informed written consent was obtained from individual parents/guardians.


  1. 1.
    Niaudet P, Boyer O. Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED, harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, editors. Pediatric nephrology. Berlin: Springer; 2016. pp. 840.Google Scholar
  2. 2.
    Bagga A, Srivastava RN. Nephrotic syndrome. In: Srivastava RN, Bagga A, editors. Pediatric nephrology. New Delhi: Jaypee Brothers medical Publishers (P) LTD; 2011. p. 195.CrossRefGoogle Scholar
  3. 3.
    Kliegman RM, Stanton BF, Geme JWS, Schor NF. Nelson textbook of pediatrics. 20th ed. In: Behrman RE, editors. Toronto: Elsevier; 2016. pp 2521–2527Google Scholar
  4. 4.
    Xu ZQ, Yi ZW, Dang XQ, Wu XC, He XJ. Relationship of 24-hour ambulatory blood pressure and rennin–angiotensin–aldosterone system in children with primary nephrotic syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12(10):788–92.Google Scholar
  5. 5.
    Xu ZQ, Yi ZW, Dang XQ, et al. Sympathetic nervous system level and ambulatory blood pressure in children with primary nephrotic syndrome. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35(7):693–8.Google Scholar
  6. 6.
    Kontchou LM, Liccioli G, Pela I. Blood pressure in children with minimal change nephrotic syndrome during oedema and after steroid therapy: the influence of familial essential hypertension. Kidney Blood Press Res. 2009;32(4):258–62.CrossRefGoogle Scholar
  7. 7.
    Küster S, Mehls O, Seidel C, Ritz E. Blood pressure in minimal change and other types of nephrotic syndrome. Am J Nephrol. 1990;10(Suppl 1):76–80.Google Scholar
  8. 8.
    Torres GAA, Kitsu MAA, Loza MJE, Keever MÁV. Cardiovascular risk factors in children with primary nephrotic syndrome. Rev Med Inst Mex Seguro Soc. 2015;53(Suppl 3):S284–93. (PubMed PMID: 26509304).Google Scholar
  9. 9.
    Gabban NI, Abdullah EA, Abdullah HN. Nephrotic syndrome and hypertension. Iraqi J Commun Med. 2010 (4);271–76.Google Scholar
  10. 10.
    Zsuzsanna A, Carmen D, Eva K, Zsigmond E, et al. Clinical features and histopathological spectrum in adolescent onset nephrotic syndrome in a Romanian Children Population. Acta Med Marisiensis. 2014;60(4):146–50.CrossRefGoogle Scholar
  11. 11.
    Paul VK, Bagga A. Ghai essential pediatrics. 8th ed. Chennai: CBS Publishers & Distributors Pvt Ltd; 2013.Google Scholar
  12. 12.
    The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.
  13. 13.
    Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol. 2005;89:1646–54.CrossRefGoogle Scholar
  14. 14.
    Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009;22:709–14.CrossRefGoogle Scholar
  15. 15.
    Assadi F. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol. 2007;28:27–33.CrossRefGoogle Scholar
  16. 16.
    Seeman T, Pohl M, Palyzova D, John U. Microalbuminuria in children with primary and white-coat hypertension. Pediatr Nephrol. 2012;27:461–7.CrossRefGoogle Scholar
  17. 17.
    Bloetzer C, Bovet P, Paccaud F, et al. Performance of targeted screening for the identification of hypertension in children. Blood Press. 2017;26(2):87–93.CrossRefGoogle Scholar
  18. 18.
    Naha NK, John M, CherianVJ. Prevalence of hypertension and risk factors among school children in Kerala, India. J Contemp Pediatr.
  19. 19.
    Haas GM, Bertsch T, Schwandr P. Prehypertension and cardiovascular risk factors in children and adolescents participating in the community-based prevention education program family heart study. Int J Prev Med. 2014;5(Suppl 1):S50–6.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Hong YM, Kang YJ. Suh S. Correlation between high blood pressure and lipid profile in children. Korean J Pediatr. 1995;38(12):1645–52.Google Scholar
  21. 21.
    Dalili S, Mohammadi H, Rezvany SM, Dadashi A, Novin MH. The relationship between blood pressure, anthropometric indices and metabolic profile in adolescents: a cross sectional study. Indian J Pediatr. 2015;82(5):445–9.CrossRefGoogle Scholar
  22. 22.
    Willaims KM, Shah AN, Morrison D, Sinha M. Demographic, clinical, and ophthalmoscopic findings from a 30 year british cohort. J Paediatr Ophthalmol Strabismus. 2013;50(4):222–8.CrossRefGoogle Scholar
  23. 23.
    Foster BJ, Ali H, Mamber S, Polomeno RC, Mackie AS. Prevalence and severity of hypertensive retinopathy in children. Clin Pediatr (Phila). 2009;48(9):926–30. (Epub 2009 Jul 1).CrossRefGoogle Scholar
  24. 24.
    Hanevold C, Waller J, Daniels S, Portman R, Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004;113(2):328–33.CrossRefGoogle Scholar
  25. 25.
    Richey PA1, Disessa TG, Somes GW, Alpert BS, Jones DP. Left ventricular geometry in children and adolescents with primary hypertension. Am J Hypertens. 2010;23(1):24–9. (Epub 2009 Oct).CrossRefGoogle Scholar
  26. 26.
    Stabouli S, Kotsis V, Rizos Z, Toumanidis S, Karagianni C. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol. 2009;24(8):1545–51. (Epub 2009 May 15).CrossRefGoogle Scholar
  27. 27.
    Sorof JM1, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal–medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics. 2003;111(1):61–6.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  1. 1.Department of PediatricsVMMC and Safdarjung HospitalDelhiIndia
  2. 2.Department of CardiologyVMMC and Safdarjung HospitalDelhiIndia
  3. 3.Department of OphthalmologyVMMC and Safdarjung HospitalDelhiIndia
  4. 4.DelhiIndia

Personalised recommendations